IVI will convene a series of webinars in 2021 to communicate research findings, explore new methodologies in value assessment, and host public dialogue on relevant issues. Join IVI for open conversations about best practices with researchers, patient organizations, policymakers, and those who pay for care.

Below are upcoming and recent IVI webinars. To view past events, visit our webinar archive here.

Featured Events

There is widespread acknowledgement that the data inputs supporting value and health technology assessment are insufficient, both in their lack of representative diversity and their failure to capture real-world factors that matter to communities living with chronic health conditions.

IVI will host a three-part webinar series to frame discussions about improving equity in research: representing patient community perspectives in the methods that support value assessment and developing policy solutions to support such initiatives. This series will build toward IVI’s second annual Methods Summit in late 2021, where both gaps and emerging approaches in improving patient-centered data inputs to research and value assessment will be examined. The three webinars will focus on identifying areas of consensus and current initiatives, as well as essential actions to propel lasting, durable change.

Session 1

Meaningful Action Toward Health Equity

Thursday, April 22, 2021

1:00 PM – 2:15 PM EDT

View Webinar

Session 2

Methods in Value Assessment that Support Equity

Thursday, June 24, 2021

2:00 PM – 3:15 PM EDT


Session 3

Policy and Partnership Solutions to Create Enduring Progress

Coming Soon!

Details To Be Announced!

After participating in this series, participants will be able to:

  • Define and discuss equity issues in the context of value assessment.

  • Consider challenges and solutions in improving representativeness in research.

  • Evaluate existing and emerging methods that support equity in value assessment.

  • Identify policy solutions at all levels that can support improvement in research equity.

Who should attend:

  • Health economics and outcomes researchers

  • Patient, family, and disease community researchers and advocates
  • Innovators from pharmaceutical, device, digital, and other healthcare industries

  • Employers

  • Insurers, pharmacy benefit managers, benefits consultants, pathway developers

  • Policymakers

Upcoming Events

Methods in Value Assessment that Support Equity

Date: Thursday, June 24, 2021
Time: 2:00 PM EDT

Bringing patient perspectives into value and health technology assessments is widely acknowledged to be lacking. In particular, data inputs typically don’t reflect patient diversity. They also fail to capture real-world factors that matter to communities living with chronic health conditions, such as whether treatments are likely to continue or even exacerbate current inequities in the health care system.

One of IVI’s nine guiding principles is improving attention to equity in health care decision-making and delivery. Join us for the second in a three-part series on health equity, featuring leading experts who are devising innovative solutions for improved data inputs and analytic methods, thus supporting patient representativeness in research and consideration of the equity impacts of new treatments.

Those attending the webinar will learn about challenges and potential solutions in improving patient representativeness in research, as well as existing and emerging methods that could support a fuller consideration of equity in value assessments.

Rick Chapman, PhD (Moderator)
Rick Chapman, PhD (Moderator)Innovation and Value Initiative
Lisa A. Prosser, PhD, MS
Lisa A. Prosser, PhD, MSSusan B. Meister Child Health Evaluation and Research Center
As Director of the Susan B. Meister Child Health Evaluation and Research Center, Dr. Prosser’s research focuses on measuring the value of childhood health interventions using the methods of decision sciences and economics. Current topics include newborn screening programs, vaccination programs, and methods for valuing family spillover effects of illness. Her research in vaccine program cost-effectiveness has been used in setting national vaccine policy.
Stacey Kowal, MSc
Stacey Kowal, MScGenentech
As Principal Researcher in Health Policy and Systems Research at Genentech, Ms. Kowal’s current work aims to increase the focus on patient-centricity and equity effects in health economics and outcomes research and health technology assessment (HTA). Her background includes both U.S. and global work to inform HTA and reimbursement as well as public health intervention design.
Shainoor Ismail, MD, MSc, FRCPC
Shainoor Ismail, MD, MSc, FRCPCPublic Health Agency of Canada and Metro City Medical Clinic
Dr. Ismail is the Medical Lead for the National Advisory Committee on Immunization’s guidance on the use of COVID-19 vaccines, and a former Deputy Chief Medical Officer of Health. She led the development of a framework for the integration of ethics, equity, feasibility and acceptability considerations in national immunization recommendations. The British Medical Journal, Global Health recently published her article, “Navigating Inequities: A Roadmap out of the Pandemic.”

Register for the Webinar


Recent Events

IVI Model Scope on Major Depressive Disorder

Date: Monday, May 3, 2021
Time: 1:00 PM EDT

IVI launched the Major Depressive Disorder (MDD) initiative to build a flexible, open-source, and patient-centric model that will help inform the decision needs of multiple stakeholders in the health care system.

According to the National Alliance on Mental Illness, over 19 million adults had at least one MDD episode in the past year; the COVID-19 pandemic has only exacerbated the unmet need for depression treatment. Conventional cost-effectiveness models for assessing the value of MDD treatments typically do not prioritize factors and outcomes important to patients.

This webinar will cover the major points of the new model scope for the MDD initiative, and address the importance of a patient-centric model for MDD. Via a public comment period from April 12th to May 14th, stakeholders are invited to provide recommendations on the most important factors to build into the model.

Rick Chapman, PhD (Moderator)
Rick Chapman, PhD (Moderator)Innovation and Value Initiative
Jessica Kennedy
Jessica KennedyMental Health America
In her role as Chief of Staff at Mental Health America, Ms. Kennedy focuses on screening, workplace mental health, public education, digital marketing, mental health policy, and program management. She launched the organization’s online screening program in 2014, now the largest database of mental health screens worldwide.
Mohannad (Ned) Kusti, MD, MPH
Mohannad (Ned) Kusti, MD, MPHPivot Onsite-Innovations
A global physician executive and healthcare consultant, Dr. Kusti has unique expertise and experience related to corporate healthcare benefits. He is consulting for numerous employers in COVID-19 corporate management. Dr. Kusti is the Corporate Medical Director at Pivot Onsite-Innovations and also teaches occupational and environmental health sciences at West Virginia University.
Richard Xie, PhD
Richard Xie, PhDInnovation and Value Initiative
A health economist and HEOR Manager at the Innovation and Value Initiative, Dr. Xie has played a lead role in developing the IVI-Major Depressive Disorder Model Scope. He has a long track record of conducting HEOR studies to inform health policy design and valuation of pharmaceutical therapies.

View Recorded Webinar


View Presentation Slides


Principles for Good Value Assessment

Date: Thursday, February 25, 2021
Time: 2:00 PM EST

In December, IVI dubbed 2021 “the year of the patient”: advancing the conversation and practice of patient-centered value assessment in tangible ways. The patient voice is crucial in achieving the promise of value assessment to improve care, achieve better outcomes, and lower costs.

In this webinar, dialogue with IVI and patient advocates about patient-centricity in action and learn more about activities for the year ahead. IVI’s new Principles for Value Assessment in the U.S. was discussed, along with their practical application for patients, employers, and researchers.

Alan Balch, PhD
Alan Balch, PhDPatient Advocate Foundation
Dr. Balch is the Chief Executive Officer of the Patient Advocate Foundation (PAF) and the National Patient Advocate Foundation (NPAF). Dr. Balch is a member of IVI’s Patient Advisory Council.
Jennifer Bright, MPA
Jennifer Bright, MPAInnovation and Value Initiative
Ms. Bright is the Executive Director of the Innovation and Value Initiative. She brings over two decades of healthcare policy, issue management, patient advocacy and executive leadership to this position.

The full recorded webinar is now available for viewing.


ISPOR-IVI Webinar Series

IVI and ISPOR collaborated, with the help from an expert advisory committee, to define and host a series of webinars highlighting key challenges confronting HEOR methodologists, patients, clinicians, and policy-makers during the COVID-19 pandemic. The webinar series explored multiple viewpoints and focused on potential pathways for solutions in international and U.S.-focused value assessment and health technology assessment (VA/HTA).

To view all five sessions, visit our webinar archive here.